Skip to main content

Table 2 Number of events of interest after the COVID-19 diagnosis

From: Risk of thrombotic events and other complications in anticoagulant users infected with SARS-CoV-2: an observational cohort study in primary health care in SIDIAP (Catalonia, Spain)

 

All COVID-19 patients

PS matched COVID-19 patients

 

Total

Non-exposed to OACa

Exposed to OAC

Total after PSa matching

Non-exposed to OAC (matched)

Exposed to OAC

N (%)

311,542

299,714

11,828

20,360

10,180

10,180

Pneumonia

5751 (1.8)

5421 (1.8)

330 (2.8)

476 (2.3)

234 (2.3)

242 (2.4)

Stroke

638 (0.2)

521 (0.2)

117 (1.0)

169 (0.8)

65 (0.6)

104 (1.0)

Pulmonary embolism

548 (0.2)

423 (0.1)

125 (1.1)

109 (0.5)

25 (0.2)

84 (0.8)

Hospital admission

18,440 (5.9)

16,636 (5.6)

1804 (15.3)

1510 (7.4)

706 (6.9)

804 (7.9)

Death

1254 (0.4)

1062 (0.4)

192 (1.6)

145 (0.7)

76 (0.7)

69 (0.7)

  1. aOAC oral anticoagulants, PS propensity score